Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 998

1.

Media magic or mayhem?

Pitts S, Forman S.

Curr Opin Pediatr. 2019 Jun 10. doi: 10.1097/MOP.0000000000000789. [Epub ahead of print] No abstract available.

PMID:
31188169
2.

Allogeneic Hematopoietic Cell Transplantation Outcomes in Patients Carrying Isocitrate Dehydrogenase Mutations.

Salhotra A, Afkhami M, Yang D, Mokhtari S, Telatar M, Gu D, Pillai RK, Weisenburger DD, Murata-Collins J, Weigel D, Aoun P, Aldoss I, Al Malki MM, Khaled S, Mei M, Ali H, Aribi A, Budde E, Sandhu K, O'Donnell M, Snyder D, Pullarkat V, Forman SJ, Marcucci G, Nakamura R, Stein A.

Clin Lymphoma Myeloma Leuk. 2019 Apr 26. pii: S2152-2650(18)31738-5. doi: 10.1016/j.clml.2019.04.007. [Epub ahead of print]

PMID:
31155409
3.

CD123 CAR T cells for the treatment of myelodysplastic syndrome.

Stevens BM, Zhang W, Pollyea DA, Winters A, Gutman J, Smith C, Budde E, Forman SJ, Jordan CT, Purev E.

Exp Hematol. 2019 May 25. pii: S0301-472X(19)30319-4. doi: 10.1016/j.exphem.2019.05.002. [Epub ahead of print]

PMID:
31136781
4.

Favorable outcomes for allogeneic hematopoietic cell transplantation in elderly patients with NPM1-mutated and FLT3-ITD-negative acute myeloid leukemia.

Aldoss I, Nakamura R, Yang D, Salhotra A, Stein AS, Pullarkat V, Forman SJ, Marcucci G.

Bone Marrow Transplant. 2019 May 14. doi: 10.1038/s41409-019-0553-x. [Epub ahead of print] No abstract available.

PMID:
31089274
5.

Impact of Sarcopenia on Adverse Outcomes After Allogeneic Hematopoietic Cell Transplantation.

Armenian SH, Xiao M, Berano Teh J, Lee B, Chang HA, Mascarenhas K, Lee S, Iukuridze A, Xie JJ, Scott JM, Jones LW, Lennie Wong F, Forman SJ, Nakamura R.

J Natl Cancer Inst. 2019 Feb 14. pii: djy231. doi: 10.1093/jnci/djy231. [Epub ahead of print]

PMID:
30951603
6.

The oral Janus kinase/spleen tyrosine kinase inhibitor ASN002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate-to-severe atopic dermatitis: results from a randomized double-blind placebo-controlled study.

Bissonnette R, Maari C, Forman S, Bhatia N, Lee M, Fowler J, Tyring S, Pariser D, Sofen H, Dhawan S, Zook M, Zammit DJ, Usansky H, Denis L, Rao N, Song T, Pavel AB, Guttman-Yassky E.

Br J Dermatol. 2019 Mar 28. doi: 10.1111/bjd.17932. [Epub ahead of print]

PMID:
30919407
7.

Adalimumab Medium-Term Dosing Strategy in Moderate-to-Severe Hidradenitis Suppurativa: Integrated Results from the Phase 3, Randomized, Placebo-Controlled, PIONEER Trials.

Jemec GBE, Okun MM, Forman SB, Gulliver WPF, Prens EP, Mrowietz U, Armstrong AW, Geng Z, Gu Y, Williams DA, Teixeira HD, Kimball AB.

Br J Dermatol. 2019 Mar 27. doi: 10.1111/bjd.17919. [Epub ahead of print]

PMID:
30916379
8.

Understanding Caregiver Quality of Life in Caregivers of Hospitalized Older Adults With Cancer.

Hsu T, Nathwani N, Loscalzo M, Chung V, Chao J, Karanes C, Koczywas M, Forman S, Lim D, Siddiqi T, Stein A, Twardowski P, Nademanee A, Pal S, Siccion E, Hein M, Akiba C, Goldstein L, Smith D, Ma H, Feng T, Hurria A.

J Am Geriatr Soc. 2019 May;67(5):978-986. doi: 10.1111/jgs.15841. Epub 2019 Mar 22.

PMID:
30901083
9.

"I's" on the prize: A systematic review of individual differences in Contingency Management treatment response.

Forster SE, DePhilippis D, Forman SD.

J Subst Abuse Treat. 2019 May;100:64-83. doi: 10.1016/j.jsat.2019.03.001. Epub 2019 Mar 7.

PMID:
30898330
10.

Effects of Anticholinesterase Reversal Under General Anesthesia on Postoperative Cardiovascular Complications: A Retrospective Cohort Study.

Shaydenfish D, Scheffenbichler FT, Kelly BJ, Lihn AL, Deng H, Nourmahnad A, Xu X, Houle TT, Eikermann M, Forman SA.

Anesth Analg. 2019 Mar 14. doi: 10.1213/ANE.0000000000004099. [Epub ahead of print]

PMID:
30896593
11.

IL15 Enhances CAR-T Cell Antitumor Activity by Reducing mTORC1 Activity and Preserving Their Stem Cell Memory Phenotype.

Alizadeh D, Wong RA, Yang X, Wang D, Pecoraro JR, Kuo CF, Aguilar B, Qi Y, Ann DK, Starr R, Urak R, Wang X, Forman SJ, Brown CE.

Cancer Immunol Res. 2019 May;7(5):759-772. doi: 10.1158/2326-6066.CIR-18-0466. Epub 2019 Mar 19.

PMID:
30890531
12.

Late mortality in blood or marrow transplant survivors with venous thromboembolism: report from the Blood or Marrow Transplant Survivor Study.

Gangaraju R, Chen Y, Hageman L, Wu J, Francisco L, Kung M, Ness E, Parman M, Weisdorf DJ, Forman SJ, Arora M, Armenian SH, Bhatia S.

Br J Haematol. 2019 Mar 18. doi: 10.1111/bjh.15866. [Epub ahead of print] No abstract available.

PMID:
30883690
13.

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function.

Wang D, Starr R, Alizadeh D, Yang X, Forman SJ, Brown CE.

J Vis Exp. 2019 Feb 27;(144). doi: 10.3791/59275.

PMID:
30882787
14.

Acute Lymphoblastic Leukemia in the Older Adult.

Aldoss I, Forman SJ, Pullarkat V.

J Oncol Pract. 2019 Feb;15(2):67-75. doi: 10.1200/JOP.18.00271.

PMID:
30763199
15.

Post-Allogeneic Hematopoietic Stem Cell Transplantation Eculizumab as Prophylaxis Against Hemolysis and Thrombosis for Patients with Hematologic Disorders Associated with Paroxysmal Nocturnal Hemoglobinuria Clones.

Mei M, Gupta R, O'Donnell M, Al Malki MM, Aldoss I, Ali H, Farol L, Snyder D, Forman SJ, Nakamura R, Khaled S.

Biol Blood Marrow Transplant. 2019 May;25(5):e183-e185. doi: 10.1016/j.bbmt.2019.01.025. Epub 2019 Jan 29.

PMID:
30708188
16.

Monod-Wyman-Changeux Allosteric Shift Analysis in Mutant α1β3γ2L GABAA Receptors Indicates Selectivity and Crosstalk among Intersubunit Transmembrane Anesthetic Sites.

Szabo A, Nourmahnad A, Halpin E, Forman SA.

Mol Pharmacol. 2019 Apr;95(4):408-417. doi: 10.1124/mol.118.115048. Epub 2019 Jan 29.

PMID:
30696720
17.

Exclusive dependence of IL-10Rα signalling on intestinal microbiota homeostasis and control of whipworm infection.

Duque-Correa MA, Karp NA, McCarthy C, Forman S, Goulding D, Sankaranarayanan G, Jenkins TP, Reid AJ, Cambridge EL, Ballesteros Reviriego C; Sanger Mouse Genetics Project; 3i consortium, Müller W, Cantacessi C, Dougan G, Grencis RK, Berriman M.

PLoS Pathog. 2019 Jan 14;15(1):e1007265. doi: 10.1371/journal.ppat.1007265. eCollection 2019 Jan.

18.

Autologous transplantation as consolidation for high risk aggressive T-cell non-Hodgkin lymphoma: a SWOG 9704 intergroup trial subgroup analysis.

Al-Mansour Z, Li H, Cook JR, Constine LS, Couban S, Stewart DA, Shea TC, Porcu P, Winter JN, Kahl BS, Smith SM, Marcellus DC, Barton KP, Mills GM, LeBlanc M, Rimsza LM, Forman SJ, Leonard JP, Fisher RI, Friedberg JW, Stiff PJ.

Leuk Lymphoma. 2019 Jan 10:1-8. doi: 10.1080/10428194.2018.1563691. [Epub ahead of print]

PMID:
30628511
19.

The Bcl-2 inhibitor venetoclax inhibits Nrf2 antioxidant pathway activation induced by hypomethylating agents in AML.

Nguyen LXT, Troadec E, Kalvala A, Kumar B, Hoang DH, Viola D, Zhang B, Nguyen DQ, Aldoss I, Ghoda L, Budde E, Pichiorri F, Rosen S, Forman SJ, Marcucci G, Pullarkat V.

J Cell Physiol. 2019 Aug;234(8):14040-14049. doi: 10.1002/jcp.28091. Epub 2019 Jan 8.

PMID:
30623427
20.

MIPSS70+ v2.0 predicts long-term survival in myelofibrosis after allogeneic HCT with the Flu/Mel conditioning regimen.

Ali H, Aldoss I, Yang D, Mokhtari S, Khaled S, Aribi A, Afkhami M, Al Malki MM, Cao T, Mei M, O'Donnell M, Salhotra A, Pullarkat V, Yang L, Stein AS, Marcucci G, Forman SJ, Nakamura R, Pillai R, Snyder D.

Blood Adv. 2019 Jan 8;3(1):83-95. doi: 10.1182/bloodadvances.2018026658.

21.

Pediatric acquired subglottic stenosis: Associated costs and comorbidities of 7,981 hospitalizations.

Arianpour K, Forman SN, Karabon P, Thottam PJ.

Int J Pediatr Otorhinolaryngol. 2019 Feb;117:51-56. doi: 10.1016/j.ijporl.2018.11.016. Epub 2018 Nov 13.

PMID:
30579088
22.

Morphological characteristics of preparator air-scribe marks: Implications for taphonomic research.

Wiest LA, Ferraro JV, Binetti KM, Forman SL, Esker DA, Kibunjia M, Brugal JP, Zechmann B.

PLoS One. 2018 Dec 20;13(12):e0209330. doi: 10.1371/journal.pone.0209330. eCollection 2018.

23.

Inhibitable photolabeling by neurosteroid diazirine analog in the β3-Subunit of human hetereopentameric type A GABA receptors.

Wu B, Jayakar SS, Zhou X, Titterton K, Chiara DC, Szabo AL, Savechenkov PY, Kent DE, Cohen JB, Forman SA, Miller KW, Bruzik KS.

Eur J Med Chem. 2019 Jan 15;162:810-824. doi: 10.1016/j.ejmech.2018.11.019. Epub 2018 Nov 19.

PMID:
30544077
24.

Effective Targeting of TAG72+ Peritoneal Ovarian Tumors via Regional Delivery of CAR-Engineered T Cells.

Murad JP, Kozlowska AK, Lee HJ, Ramamurthy M, Chang WC, Yazaki P, Colcher D, Shively J, Cristea M, Forman SJ, Priceman SJ.

Front Immunol. 2018 Nov 19;9:2268. doi: 10.3389/fimmu.2018.02268. eCollection 2018.

25.

Pre-Clovis projectile points at the Debra L. Friedkin site, Texas-Implications for the Late Pleistocene peopling of the Americas.

Waters MR, Keene JL, Forman SL, Prewitt ER, Carlson DL, Wiederhold JE.

Sci Adv. 2018 Oct 24;4(10):eaat4505. doi: 10.1126/sciadv.aat4505. eCollection 2018 Oct.

26.

Etomidate Effects on Desensitization and Deactivation of α4β3δ GABAA Receptors Inducibly Expressed in HEK293 TetR Cells.

Liao Y, Liu X, Jounaidi Y, Forman SA, Feng HJ.

J Pharmacol Exp Ther. 2019 Jan;368(1):100-105. doi: 10.1124/jpet.118.252403. Epub 2018 Nov 2.

PMID:
30389723
27.

Adults with Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia: Considerations for Allogeneic Hematopoietic Cell Transplantation in First Complete Remission.

Aldoss I, Kamal MO, Forman SJ, Pullarkat V.

Biol Blood Marrow Transplant. 2019 Feb;25(2):e41-e45. doi: 10.1016/j.bbmt.2018.09.041. Epub 2018 Oct 5.

PMID:
30292743
28.

A survey of physician practices on the inpatient medical stabilization of patients with avoidant/restrictive food intake disorder.

Guss CE, Richmond TK, Forman S.

J Eat Disord. 2018 Sep 26;6:22. doi: 10.1186/s40337-018-0212-4. eCollection 2018.

29.

Outcomes of Patients with Recurrent and Refractory Lymphoma Undergoing Allogeneic Hematopoietic Cell Transplantation with BEAM Conditioning and Sirolimus- and Tacrolimus-Based GVHD Prophylaxis.

Salhotra A, Mei M, Stiller T, Mokhtari S, Herrera AF, Chen R, Popplewell L, Zain J, Ali H, Sandhu K, Budde E, Nademanee A, Forman SJ, Nakamura R.

Biol Blood Marrow Transplant. 2019 Feb;25(2):287-292. doi: 10.1016/j.bbmt.2018.09.009. Epub 2018 Sep 15.

PMID:
30227232
30.

Ruxolitinib as Salvage Therapy for Chronic Graft-versus-Host Disease.

Modi B, Hernandez-Henderson M, Yang D, Klein J, Dadwal S, Kopp E, Huelsman K, Mokhtari S, Ali H, Malki MMA, Spielberger R, Salhotra A, Parker P, Forman S, Nakamura R.

Biol Blood Marrow Transplant. 2019 Feb;25(2):265-269. doi: 10.1016/j.bbmt.2018.09.003. Epub 2018 Sep 8.

PMID:
30201397
31.

Assessment of Late Mortality Risk After Allogeneic Blood or Marrow Transplantation Performed in Childhood.

Holmqvist AS, Chen Y, Wu J, Battles K, Bhatia R, Francisco L, Hageman L, Kung M, Ness E, Parman M, Salzman D, Wadhwa A, Winther JF, Rosenthal J, Forman SJ, Weisdorf DJ, Armenian SH, Arora M, Bhatia S.

JAMA Oncol. 2018 Dec 1;4(12):e182453. doi: 10.1001/jamaoncol.2018.2453. Epub 2018 Dec 13.

PMID:
30054602
32.

Prediction of cardiovascular disease among hematopoietic cell transplantation survivors.

Armenian SH, Yang D, Teh JB, Atencio LC, Gonzales A, Wong FL, Leisenring WM, Forman SJ, Nakamura R, Chow EJ.

Blood Adv. 2018 Jul 24;2(14):1756-1764. doi: 10.1182/bloodadvances.2018019117.

33.

Acute lymphoblastic leukemia as a clonally unrelated second primary malignancy after multiple myeloma.

Aldoss I, Capelletti M, Park J, Pistofidis RS, Pillai R, Stiller T, Sanchez JF, Forman SJ, Ghobrial IM, Krishnan A.

Leukemia. 2019 Jan;33(1):266-270. doi: 10.1038/s41375-018-0213-y. Epub 2018 Jul 19.

PMID:
30026571
34.

Effect of Repetitive Transcranial Magnetic Stimulation on Treatment-Resistant Major Depression in US Veterans: A Randomized Clinical Trial.

Yesavage JA, Fairchild JK, Mi Z, Biswas K, Davis-Karim A, Phibbs CS, Forman SD, Thase M, Williams LM, Etkin A, O'Hara R, Georgette G, Beale T, Huang GD, Noda A, George MS; VA Cooperative Studies Program Study Team.

JAMA Psychiatry. 2018 Sep 1;75(9):884-893. doi: 10.1001/jamapsychiatry.2018.1483.

PMID:
29955803
35.

Multi-center phase II trial of bortezomib and rituximab maintenance combination therapy in patients with mantle cell lymphoma after consolidative autologous stem cell transplantation.

Chen RW, Palmer JM, Tomassetti S, Popplewell LL, Alluin J, Chomchan P, Nademanee AP, Siddiqi T, Tsai NC, Chen L, Zuo F, Abary R, Cai JL, Herrera AF, Rossi JJ, Rosen ST, Forman SJ, Kwak LW, Holmberg LA.

J Hematol Oncol. 2018 Jun 28;11(1):87. doi: 10.1186/s13045-018-0631-3.

36.

Late mortality after allogeneic blood or marrow transplantation in childhood for leukemia: a report from the Blood or Marrow Transplant Survivor Study-2.

Holmqvist AS, Chen Y, Wu J, Kung M, Ness E, Parman M, Francisco L, Hageman L, Battles K, Bhatia R, Salzman D, Winther JF, Rosenthal J, Forman SJ, Weisdorf DJ, Armenian SH, Arora M, Bhatia S.

Leukemia. 2018 Dec;32(12):2706-2709. doi: 10.1038/s41375-018-0171-4. Epub 2018 Jun 26. No abstract available.

PMID:
29946190
37.

Therapy-related acute lymphoblastic leukemia has distinct clinical and cytogenetic features compared to de novo acute lymphoblastic leukemia, but outcomes are comparable in transplanted patients.

Aldoss I, Stiller T, Tsai NC, Song JY, Cao T, Bandara NA, Salhotra A, Khaled S, Aribi A, Al Malki MM, Mei M, Ali H, Spielberger R, O'Donnell M, Snyder D, Slavin T, Nakamura R, Stein AS, Forman SJ, Marcucci G, Pullarkat V.

Haematologica. 2018 Oct;103(10):1662-1668. doi: 10.3324/haematol.2018.193599. Epub 2018 Jun 14.

38.

High-throughput Screening in Larval Zebrafish Identifies Novel Potent Sedative-hypnotics.

Yang X, Jounaidi Y, Dai JB, Marte-Oquendo F, Halpin ES, Brown LE, Trilles R, Xu W, Daigle R, Yu B, Schaus SE, Porco JA Jr, Forman SA.

Anesthesiology. 2018 Sep;129(3):459-476. doi: 10.1097/ALN.0000000000002281.

PMID:
29894316
39.

Regulation of miR-34b/c-targeted gene expression program by SUMOylation.

Li YJ, Du L, Aldana-Masangkay G, Wang X, Urak R, Forman SJ, Rosen ST, Chen Y.

Nucleic Acids Res. 2018 Aug 21;46(14):7108-7123. doi: 10.1093/nar/gky484.

40.

Castration induces satellite cell activation that contributes to skeletal muscle maintenance.

Klose A, Liu W, Paris ND, Forman S, Krolewski JJ, Nastiuk KL, Chakkalakal JV.

JCSM Rapid Commun. 2018;1(1). pii: e00040.

41.

Glioblastoma-targeted CD4+ CAR T cells mediate superior antitumor activity.

Wang D, Aguilar B, Starr R, Alizadeh D, Brito A, Sarkissian A, Ostberg JR, Forman SJ, Brown CE.

JCI Insight. 2018 May 17;3(10). pii: 99048. doi: 10.1172/jci.insight.99048. eCollection 2018 May 17.

42.

Melphalan-Based Reduced-Intensity Conditioning is Associated with Favorable Disease Control and Acceptable Toxicities in Patients Older Than 70 with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.

Al Malki MM, Nathwani N, Yang D, Armenian S, Dadwal S, Salman J, Mokhtari S, Cao T, Sandhu K, Rouse M, Mei M, Ali H, Parker P, Alvarnas J, Smith E, Donnell MO, Marcucci G, Snyder D, Nademanee A, Forman SJ, Stein A, Nakamura R.

Biol Blood Marrow Transplant. 2018 Sep;24(9):1828-1835. doi: 10.1016/j.bbmt.2018.04.029. Epub 2018 May 9.

PMID:
29753158
43.

Stemming the tide of abuse: clinicians' role in the #MeToo movement.

Pitts S, Forman S.

Curr Opin Pediatr. 2018 Aug;30(4):449-450. doi: 10.1097/MOP.0000000000000634. No abstract available.

PMID:
29750771
44.

PET of Adoptively Transferred Chimeric Antigen Receptor T Cells with 89Zr-Oxine.

Weist MR, Starr R, Aguilar B, Chea J, Miles JK, Poku E, Gerdts E, Yang X, Priceman SJ, Forman SJ, Colcher D, Brown CE, Shively JE.

J Nucl Med. 2018 Oct;59(10):1531-1537. doi: 10.2967/jnumed.117.206714. Epub 2018 May 4.

45.

A Future for Autologous Hematopoietic Stem Cell Transplantation in Type 1 Diabetes.

van Megen KM, van 't Wout ET, Forman SJ, Roep BO.

Front Immunol. 2018 Apr 6;9:690. doi: 10.3389/fimmu.2018.00690. eCollection 2018. No abstract available.

46.

Late mortality after autologous blood or marrow transplantation in childhood: a Blood or Marrow Transplant Survivor Study-2 report.

Holmqvist AS, Chen Y, Wu J, Battles K, Bhatia R, Francisco L, Hageman L, Kung M, Ness E, Parman M, Salzman D, Winther JF, Rosenthal J, Forman SJ, Weisdorf DJ, Arora M, Armenian SH, Bhatia S.

Blood. 2018 Jun 14;131(24):2720-2729. doi: 10.1182/blood-2018-02-831156. Epub 2018 Apr 16.

47.

Combining Mutations and Electrophysiology to Map Anesthetic Sites on Ligand-Gated Ion Channels.

Forman SA.

Methods Enzymol. 2018;602:369-389. doi: 10.1016/bs.mie.2018.01.014. Epub 2018 Feb 28. Review.

48.

Efficacy of the combination of venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia.

Aldoss I, Yang D, Aribi A, Ali H, Sandhu K, Al Malki MM, Mei M, Salhotra A, Khaled S, Nakamura R, Snyder D, O'Donnell M, Stein AS, Forman SJ, Marcucci G, Pullarkat V.

Haematologica. 2018 Sep;103(9):e404-e407. doi: 10.3324/haematol.2018.188094. Epub 2018 Mar 15. No abstract available.

49.

Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia.

Zhang B, Nguyen LXT, Li L, Zhao D, Kumar B, Wu H, Lin A, Pellicano F, Hopcroft L, Su YL, Copland M, Holyoake TL, Kuo CJ, Bhatia R, Snyder DS, Ali H, Stein AS, Brewer C, Wang H, McDonald T, Swiderski P, Troadec E, Chen CC, Dorrance A, Pullarkat V, Yuan YC, Perrotti D, Carlesso N, Forman SJ, Kortylewski M, Kuo YH, Marcucci G.

Nat Med. 2018 May;24(4):450-462. doi: 10.1038/nm.4499. Epub 2018 Mar 5.

50.

Health surveillance for occupational asthma.

Fishwick D, Forman S.

Curr Opin Allergy Clin Immunol. 2018 Apr;18(2):80-86. doi: 10.1097/ACI.0000000000000424. Review.

PMID:
29461276

Supplemental Content

Loading ...
Support Center